Evolution of the Average Target: Aptiv PLC

Evolution of the Target Price: Aptiv PLC

Changes in Analyst Recommendations: Aptiv PLC

c531e14beccc83ef3b5593d1ae87e.XMDFv704KLLBLwgGkoOjn6HbSpp-qg2-4ftuGnZ5uXM.FrCGi_ldG8v0XEsw-O_V59XsBag84m7L1rgjYwIVjRU-iaDI7mt_9KtIUQ~3c6c8bbc92a9899c7674c197c1b1b8d2
BNP Paribas Exane Adjusts Price Target on Aptiv to $83 From $80, Maintains Outperform Rating Jul. 18 MT
Analyst recommendations: Airbnb, Dexcom, Gitlab, AMD, Citigroup… Jul. 16Zonebourse
UBS Adjusts Price Target on Aptiv to $75 From $66, Maintains Buy Rating Jul. 14 MT
Baird Adjusts Aptiv's Price Target to $82 From $80, Keeps Outperform Rating Jul. 11 MT
RBC Raises Price Target on Aptiv to $85 From $77, Keeps Outperform Rating Jul. 09 MT
Wolfe Research Downgrades Aptiv to Peer Perform From Outperform Jul. 02 MT
Wells Fargo Adjusts Price Target on Aptiv to $86 From $85, Maintains Overweight Rating Jul. 01 MT
Guggenheim Downgrades Aptiv to Neutral Jun. 04 MT
Daiwa Securities Adjusts Price Target on Aptiv to $77 From $66, Maintains Outperform Rating May. 30 MT
Piper Sandler Adjusts Price Target on Aptiv to $70 From $67, Maintains Neutral Rating May. 22 MT
Baird Adjusts Price Target on Aptiv to $80 From $70, Maintains Outperform Rating May. 21 MT
Morgan Stanley Adjusts Aptiv Price Target to $55 From $60, Maintains Underweight Rating May. 19 MT
Wells Fargo Adjusts Price Target on Aptiv to $85 From $75, Maintains Overweight Rating May. 19 MT
BNP Paribas Exane Adjusts Price Target on Aptiv to $80 From $75 May. 05 MT
Barclays Adjusts Aptiv Price Target to $65 From $55, Maintains Equal Weight Rating May. 05 MT
Analyst recommendations: Amazon, PepsiCo, Linde, Pfizer, Crowdstrike Holdings... May. 05Zonebourse
TD Cowen Adjusts Aptiv Price Target to $90 From $86 May. 02 MT
JPMorgan Adjusts Aptiv Price Target to $85 From $84 May. 02 MT
Daiwa Securities Adjusts Aptiv Price Target to $66 From $73 May. 02 MT
Wells Fargo Adjusts Aptiv Price Target to $75 From $77 May. 02 MT
Baird Adjusts Aptiv Price Target to $70 From $65 May. 02 MT
Oppenheimer Adjusts Aptiv Price Target to $84 From $85 May. 02 MT
Deutsche Bank Adjusts Aptiv Price Target to $67 From $63 May. 02 MT
Wolfe Research Adjusts Price Target on Aptiv to $68 From $72 May. 02 MT
UBS Adjusts Aptiv Price Target to $66 From $58, Maintains Neutral Rating May. 02 MT
More recommendations

Consensus (Composite) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Ecart obj. / dr
+15.41%
+22.38%
+19.39%
+13.58%
+12.95%
+9.3%
+7.31%
+11.84%
+37.06%
Average +16.58%
Weighted average by Cap. +16.70%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
68.20USD
Average target price
78.71USD
Spread / Average Target
+15.41%
High Price Target
95.00USD
Spread / Highest target
+39.30%
Low Price Target
55.00USD
Spread / Lowest Target
-19.35%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas Exane
UBS
Baird
RBC Capital Markets
Wolfe Research
Wells Fargo Securities
Guggenheim
Daiwa Securities
Piper Sandler
Morgan Stanley
Barclays
TD Cowen
JPMorgan Chase
Oppenheimer
Deutsche Bank Securities
BofA Securities
Evercore ISI
HSBC
Raymond James
Goldman Sachs
DA Davidson
Nomura
Argus
National Securities
Citigroup
Berenberg Bank
Cowen
Credit Suisse
B. Riley
Jefferies & Co.
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings

Quarterly revenue - Rate of surprise